Gilde Healthcare
Venture Capital. Series A – Growth, checks €10M–€50M.
- Stages
- Series A, Series B, Growth
- Check size
- €10M–€50M
- Focus
- Health & Bio
- Invests in
- Europe, US
- Offices
- Utrecht, Netherlands; Frankfurt, Germany; Boston, United States
- Latest fund
- €740M
- Website
- gildehealthcare.com
About
Gilde Healthcare runs three separate strategies: Venture&Growth, its venture strategy; Private Equity, which buys into profitable healthcare providers and suppliers; and Climate Solutions, a private equity fund for the energy transition. Pieter van der Meer and Edwin de Graaf are the managing partners of Venture&Growth, with Stefan Luzi as partner for therapeutics and Joep Muijrers as general partner for public investments. Besides its home base the firm keeps offices in Frankfurt and Boston. The venture team mixes investment managers, former scientists, sector experts and serial entrepreneurs, and works hands-on with portfolio companies on growth strategy and international expansion. It takes significant minority stakes. Its thesis is that the best value in healthcare comes from better care at lower cost, and an Impact Council chaired by a former executive director of the European Medicines Agency advises on that mission.
Notable investments
- Inari Medical
- Withings
- Axonics
- Ascendis Pharma
- uniQure
- Ablynx
Last checked 13 November 2026. Something wrong or out of date? Write to hi@schub.tech.
Building a company in Europe? Schub invests €25k for 2% and gives you a weekly 1:1 with a founder coach.
Apply to Schub